Dr. Avinash M. Murthy, MD
Interventional Cardiology (Interventional Cardiology Physician)
- Medicare participating
At a glance
- Years since graduation
- 24
- In the NPI registry since
- 2008
- Medicare patients seen, 2024
- 1,724
Licensed in Illinois since 2014, according to the Illinois Department of Financial and Professional Regulation. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2008Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Interventional Cardiology Physician primary
IL license 036.135341 (first issued 2014; active) · LA license 308508 -
Cardiovascular Disease Physician
IL license 036.135341 (first issued 2014; active)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- St Johns Hospital Springfield, IL
- St Anthonys Memorial Hospital Effingham, IL
- St Francis Hospital Litchfield, IL
- Hshs Holy Family Hospital Inc Greenville, IL
- Hshs Good Shepherd Hospital Inc Shelbyville, IL
Medical groups
- Sarah Bush Lincoln Health Center (419 clinicians)
- Prairie Cardiovascular Consultants LTD (90 clinicians)
- Hillsboro Area Hospital, Inc. (38 clinicians)
- Thomas H Boyd Memorial Hospital (32 clinicians)
- St Johns Hospital of the Hospital Sisters of the Third Order of St F (26 clinicians)
- St Anthonys Memorial Hospital of the Hospital Sisters of the Third (25 clinicians)
- Hshs Holy Family Hospital Inc (25 clinicians)
- St Francis Hospital of the Hospital Sisters of the Third Order of St F (14 clinicians)
- St Marys Hospital Decatur of the Hospital Sisters of the Third Order (11 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 1,724
- Services billed
- 4,342
- Patients’ average age
- 75
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 478 | 358 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 353 | 329 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 234 | 110 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 230 | 216 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 222 | 191 |
| Ultrasound of both sides of head and neck blood flow | 149 | 144 |
| Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 129 | 118 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 93 | 86 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 91 | 74 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 68 | 64 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Atorvastatin Calcium Other prescribers in Springfield, IL | 676 |
| Amlodipine Besylate Other prescribers in Springfield, IL | 421 |
| Clopidogrel (clopidogrel bisulfate) Other prescribers in Springfield, IL | 303 |
| Metoprolol Succinate Other prescribers in Springfield, IL | 301 |
| Metoprolol Tartrate Other prescribers in Springfield, IL | 271 |
| Ranolazine Er (ranolazine) Other prescribers in Springfield, IL | 244 |
| Eliquis (apixaban) Other prescribers in Springfield, IL | 243 |
| Hydrochlorothiazide Other prescribers in Springfield, IL | 201 |
| Xarelto (rivaroxaban) Other prescribers in Springfield, IL | 194 |
| Jardiance (empagliflozin) Other prescribers in Springfield, IL | 182 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 9 companies reported 18 payments worth $1,151 in total to this clinician.
| Medtronic, Inc. | $339 |
|---|---|
| Shockwave Medical, Inc | $211 |
| Teleflex LLC | $153 |
| Abiomed | $148 |
| Philips North America LLC | $146 |
| Novartis Pharmaceuticals Corporation | $77.20 |
| Boston Scientific Corporation | $43.39 |
| Pfizer Inc. | $25.05 |
| Food and Beverage | $981 |
|---|---|
| Travel and Lodging | $170 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Medtronic, Inc. Jun 27, 2025 | Travel and Lodging SYMPLICITY G3 · Renal Denervation System · travel to Rosemont, IL · in-kind | $149 |
| Medtronic, Inc. Jun 27, 2025 | Travel and Lodging SYMPLICITY G3 · Renal Denervation System · travel to Rosemont, IL · in-kind | $20.86 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 5 industry-funded studies in 2025, from 5 companies. The companies reported $93,348 in research payments for these studies, mostly to the institutions running them.
- A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or O…
Amgen Inc. - Randomized, Double-blind, Placebo-controlled, Multicenter Trial, Assessing the Impact of Inclisiran on Major Adverse Cardiovascular Events in Participants With Established Cardiovascular Disease (VICTORION-2 PREVENT)
Novartis Pharmaceuticals Corporation - A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome (LIBREXIA-ACS)
Janssen Research & Development, LLC - Global Symplicity Registry Define
Medtronic, Inc. - Drug-Eluting Registry: Real-World Treatment of Lesions in the Peripheral Vasculature
Boston Scientific Corporation · Recruiting · NCT04674969
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.